Discover Great Companies Discover Great Clients
Popularity  17.3万   |   Followers  128   |   Likes  46   |   Feedback  123 Claim this company

A modern pharmaceutical enterprise spanning three major fields: modern

No.30 Yantai City Popularity Ranking No.13 Development Zone No.293 Shandong P No.1 Research Institute No.2 Zhong Pharmaceuticals No.2 Biopharmaceuticals No.2 Biotechnology Pharmaceuticals No.3 Sheng Wu Ke Ji / Biotechnology Engineering No.3 Biological Products No.3 Healthcare Technology No.4 Lin Chuang Yi Xue No.4 Yao Products R&D No.4 Pharmaceutical Technology No.5 Hua Gong / Chemistry No.5 Zhi Yao / Yao Industries 民营科技企业 博士后工作站 省级高新技术企业 高新技术企业 省级创新型中小企业 企业技术中心
More

Company Overview

  • Nature: Joint Venture Size: 1000-4999 employees Founded: 33年
  • Industry: Pharmaceuticals/Bioengineering 、 Raw Materials and Processing 、 Academic/Scientific Research
  • Full name: Yantai Rongchang Pharmaceutical Co., Ltd.。

Development Stage

  • Ranking: Ranked #30 in Yantai City by popularity Ranked #1 in Yantai Research Institute Company by popularity Ranked #2 in Yantai Zhong Pharmaceuticals Company by popularity Ranked #2 in Yantai Biopharmaceuticals Company by popularity Ranked #2 in Yantai Biotechnology Pharmaceuticals Company by popularity
  • Honors: 民营科技企业 博士后工作站 According to algorithm
  • Salary: 82.3% of positions earn 6-10K, In 2026 vs last yeargrew by 21%.。Master's salary: ¥28.3K, Doctorate salary: ¥43.3K.
  • R&D: "Medical & Health/Beauty & Healthcare" demand: 3.2%, "Computer/Network/Technology": 2.6%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 2.4%。
  • Recruiting: In 2026 vs 2025decreased by 1%. Demand for highly educated talent: Master's: 17, Doctorate: 7.
  • Requirement: Education: 大专 leads with 73.2%. Experience: 1-3年 leads with 66%.
  • Region: Distributed across 51 regions, 烟台: 7.7%, 杭州: 4.7%, 上海: 3.5%, 武汉: 2.3%.

About the Company

[Summary] A modern pharmaceutical enterprise spanning three major fields: modern

Founded in 1993, Rongchang Group comprises Rongchang Pharmaceutical, Rongchang Bio (stock code: 9995.HK), MabPlex, Rongchang Zibo, and Yeda Incubation Center, integrating R&D, production, sales, and services, and spanning four major fields: modern Chinese medicine, biopharmaceuticals, biopharmaceutical R&D and manufacturing services (CDMO), and incubation of biomedical enterprises and projects.
In the field of Chinese medicine, the company holds over 90 drug production approvals. Among them, the flagship products are the Gantai and Tianmeng series. In addition, Jiannaobusu Pills, Daqingye series, Shiwei, Xiao'er Dingchuan Oral Liquid, Kunning Oral Liquid, and Compound Jingjie Fumigation Lotion are also well received in the market.
In the biopharmaceutical field, the company is committed to discovering, developing, and commercializing first-in-class and best-in-class biopharmaceuticals, creating a number of innovative biological drugs with significant clinical value for major diseases such as autoimmunity, tumors, and ophthalmology. The company has an R&D and management team led by senior experts and has undertaken more than ten national 'Major New Drug Innovation' science and technology projects and national '863' projects. Among them, the national Class I innovative biological drug 'Tai'ai' (Telitacicept) for the treatment of systemic lupus erythematosus (SLE) has been approved for marketing, bringing a major breakthrough in SLE treatment. The investigational RC48 (Disitamab Vedotin) is the first antibody-drug conjugate (ADC) new drug in China to enter human trials, used for the treatment of HER2-overexpressing cancers such as gastric cancer, urothelial carcinoma, and breast cancer, with the gastric cancer indication already launched in China. In addition, more than ten other innovative biological drugs are at various stages of R&D.
In the CDMO field, MabPlex is one of the few CDMO companies globally that can provide end-to-end services from ADC drug development to commercial production. It serves as the undertaking unit of Shandong Province's public service platform for antibody drug development and industrialization, is a national high-tech enterprise, and has established a branch in San Diego, USA, with the United States as its overseas center to radiate into the European and American markets.
The company has been recognized by government organizations at various levels as a National Torch Plan Key High-Tech Enterprise, a National (Enterprise) Innovative Drug Incubation Base, and a National Comprehensive New Drug R&D Technology Platform (Shandong) Industrialization Demonstration Enterprise, and has established a postdoctoral research workstation and a Shandong Province Academician Workstation and other innovation platforms.
The Group adheres to a people-oriented approach, values talent cultivation and team building, and provides employees with comprehensive benefits, broad development opportunities and platforms, and professional training and further education opportunities.
Rongchang Group welcomes you to join us! Join hands with Rongchang Group to improve the quality of life through science and create a bright future together!

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Rongchang Pharmaceutical How Fast Is Hiring Growing? (292 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 95%
  • 2024: Up 105%
  • 2023: Up 106%
  • 2022: Down 90%
Rongchang Pharmaceutical Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Rongchang Pharmaceutical Campus Recruitment & Advanced Degree Talent Demand
Graduates 1 Master's 17 Doctorate 7
No.72
Company Recruitment Ranking in Yantai City 򀀩
No.210
Recruitment Growth Ranking in Yantai City 򀀩
No.45
Graduate Talent Ranking in Yantai City 򀀩
Note: How fast is hiring at Yantai Rongchang Pharmaceutical Co., Ltd. growing? Rongchang Pharmaceutical2026: 516 openings (down 1%), 2025: 521 openings (up 95%), 2024: 267 openings (up 105%), 2023: 130 openings (up 106%), 2022: 63 openings (down 90%), 2021: 612 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Rongchang Pharmaceutical Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Up 133%
  • 2024: Flat 0%-
  • 2023: Down 82%
  • 2022: Down 50%
Rongchang Pharmaceutical Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Yantai Rongchang Pharmaceutical Co., Ltd. growing? Rongchang PharmaceuticalMaster's recruitment over the years: 2025: 7 openings (up 133%), 2024: 3 openings (flat), 2023: 3 openings (down 82%), 2022: 17 openings (down 50%), 2021: 34 openings. Rongchang Pharmaceutical master talent ranking in Yantai: #14, Rongchang Pharmaceutical master salary mostly around 10-50K.

Rongchang Pharmaceutical Doctoral Degree Job Demand Analysis

(More)
+80%
Growth Rate
2026 vs 2025
  • 2025: Up 67%
  • 2024: Down 57%
  • 2023: Down 30%
  • 2022: Down 23%
Rongchang Pharmaceutical Doctoral Hiring by Year: 2026 — 4 more jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Yantai Rongchang Pharmaceutical Co., Ltd. growing? Rongchang PharmaceuticalDoctorate recruitment over the years: 2026: 9 openings (up 80%), 2025: 5 openings (up 67%), 2024: 3 openings (down 57%), 2023: 7 openings (down 30%), 2022: 10 openings (down 23%), 2021: 13 openings. Rongchang Pharmaceutical doctorate talent ranking in Yantai: #7, Rongchang Pharmaceutical doctorate salary mostly around 30-50K and above.

Rongchang Pharmaceutical R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Yantai Rongchang Pharmaceutical Co., Ltd.? Based on an analysis of Rongchang Pharmaceutical's job postings over the past year, "Medical & Health/Beauty & Healthcare" demand: 3.2%, "Computer/Network/Technology": 2.6%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 2.4%, "Other (R&D and Technical)": 0.9%, "Scientific Research": 0.3%, "Electrical/Energy/Power": 0.2%. For reference only.

Rongchang Pharmaceutical — What Are the Salaries Like? (664 records)

Manage
Rongchang Pharmaceutical Salary Overview
salary range: 4.5K - 50K, 82.3% of roles pay ¥6-10K
Note: salary statistics are based on 664 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Yantai Rongchang Pharmaceutical Co., Ltd.?Rongchang Pharmaceutical82.3% of positions earn 6-10K, Fresh graduate salary: ¥12.5K。Yantai salary ranking top 50,Sales average salary ¥7.6K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Rongchang Pharmaceutical

(More)
Are salaries high at Yantai Rongchang Pharmaceutical Co., Ltd.? We provide: Academic Specialist, Leasing Manager, OTC Manager, Promotion Specialist, Pharmaceutical Sales Representative, Business Specialist, Operations, OTC Representative, Product Manager, DM, Business Development, Planner, Sales, 临床, Marketing, Promoter, Chemistry, Medical Director, 合规, New Media Specialist. Click to view detailed salary analysis by job.

Rongchang Pharmaceutical honors, qualifications & industry associations

Job Category

  • Sales
    83.6% of total 83.6%
  • Marketing/PR/Media
    6.3% of total 6.3%
  • Business Management
    5.1% of total 5.1%
  • Trade/Logistics/Procurement/Transportation
    3.8% of total 3.8%

Education

  • 大专
    73.2% of total 73.2%
  • 本科
    19.3% of total 19.3%
  • 硕士
    3.9% of total 3.9%
  • 博士
    1.8% of total 1.8%

Experience

  • 1-3年
    66% of total 66%
  • 不限
    22.4% of total 22.4%
  • 3-5年
    7.4% of total 7.4%
  • 5-10年
    4.1% of total 4.1%
View Detailed Analysis

What does Yantai Rongchang Pharmaceutical Co., Ltd. require? Who is Rongchang Pharmaceutical hiring? Rongchang Pharmaceutical recruitment: Sales占比最多占83.6%,其次是Marketing/PR/Media占6.3%. What education can get in at Rongchang Pharmaceutical? 大专占比最多占73.2%,其次是本科占19.3%. High education required at Rongchang Pharmaceutical? 硕士占3.9%,博士占1.8%. Work experience required at Rongchang Pharmaceutical? 1-3年占比最多占66%,其次是不限占22.4%. Where are the job locations at Rongchang Pharmaceutical? 烟台占比最多占7.7%,其次是杭州占4.7%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 15,042.767万(元)
Legal Representative: 王荔强
Date Established:
Credit Code: 913706006134130784
Registered Address: 中国(山东)自由贸易试验区烟台片区烟台开发区北京中路56号

Partners & Suppliers

荣昌制药入驻蓝色药谷园区,签订入驻及服务合同 Source
供应商 医药制造/研发
为荣昌制药提供制药设备 Source
供应商 制药设备
为荣昌制药提供制药设备如冻干机等 Source
供应商 制药设备
为荣昌制药提供药品仓储和配送服务 Source
供应商 物流服务
为荣昌制药提供药品冷链物流服务 Source
供应商 物流服务

People who follow Rongchang Pharmaceutical also follow

Rongchang Pharmaceutical Competitors (Similar Companies)

“Research and development of new drugs for major diseases such as malig”
“Customer-oriented, Efficient operations, Empower employees”
“生化原料药生产”
“To become a world-class chemical new materials company with global ope”
“National Innovative Demonstration Enterprise for Pharmaceutical Distri”
机械制造/生产/加工 取样机 工程设计 选矿设备
工程机械 马达 液压破碎锤 震动夯
工程设计 压缩设备 油气工程 油田技术服务
“高性能纤维研发生产基地”
“Energy management system solution provider”
化工/化学 杀菌剂 表面活性剂 化妆品原料
“国内规模大、效益好的轮胎专业生产企业”
钕铁硼 烧结钕铁硼 稀土永磁 生产
复合材料 聚氨酯 建筑节能材料 外墙保温
“High-tech enterprise specializing in the development of uncooled infra”

Discover Great Companies, Discover Great Clients

烟台公司名录 烟台“Development Zone”公司名录 烟台“制药/药业”公司名录 烟台“医药”公司名录 烟台“药物研发”公司名录 烟台“生物制品”公司名录 烟台“生物医药”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates